| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
15,080,000 |
| Market
Cap: |
20.96(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.42 - $2.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
23,696 |
| Total Buy Value |
$0 |
$0 |
$0 |
$55,432 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
388 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kazimi A J |
Chairman and CEO |
• • • |
2023-08-18 |
4 |
A |
$1.70 |
$111 |
D/D |
65 |
5,716,348 |
|
- |
|
| Young Caroline |
|
– • – |
2023-08-18 |
4 |
A |
$1.70 |
$111 |
D/D |
65 |
20,782 |
|
- |
|
| Jones James |
|
– • – |
2023-08-18 |
4 |
A |
$1.70 |
$111 |
D/D |
65 |
27,488 |
|
- |
|
| Krogulski Kenneth |
|
– • – |
2023-08-17 |
4 |
A |
$1.73 |
$562 |
D/D |
325 |
210,605 |
|
- |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2023-08-17 |
4 |
A |
$1.70 |
$111 |
D/D |
65 |
5,716,283 |
|
- |
|
| Young Caroline |
|
– • – |
2023-08-17 |
4 |
A |
$1.70 |
$111 |
D/D |
65 |
20,717 |
|
- |
|
| Jones James |
|
– • – |
2023-08-17 |
4 |
A |
$1.70 |
$111 |
D/D |
65 |
27,423 |
|
- |
|
| Krogulski Kenneth |
|
– • – |
2023-08-16 |
4 |
A |
$1.67 |
$543 |
D/D |
325 |
210,280 |
|
- |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2023-08-16 |
4 |
A |
$1.64 |
$107 |
D/D |
65 |
5,716,218 |
|
- |
|
| Young Caroline |
|
– • – |
2023-08-16 |
4 |
A |
$1.64 |
$107 |
D/D |
65 |
20,652 |
|
- |
|
| Jones James |
|
– • – |
2023-08-16 |
4 |
A |
$1.64 |
$107 |
D/D |
65 |
27,358 |
|
- |
|
| Jones James |
Director |
– • – |
2023-03-24 |
4 |
A |
$1.97 |
$1,970 |
D/D |
1,000 |
27,293 |
|
- |
|
| Krogulski Kenneth |
Director |
– • – |
2023-03-24 |
4 |
A |
$1.97 |
$9,850 |
D/D |
5,000 |
209,955 |
|
- |
|
| Brown Martin S Jr |
Director |
– • – |
2023-03-24 |
4 |
A |
$1.97 |
$1,970 |
D/D |
1,000 |
5,000 |
|
- |
|
| Young Caroline |
Director |
– • – |
2023-03-24 |
4 |
A |
$1.97 |
$1,970 |
D/D |
1,000 |
20,587 |
|
- |
|
| Galante Joseph C |
Director |
– • – |
2023-03-24 |
4 |
A |
$1.92 |
$1,920 |
D/D |
1,000 |
58,356 |
|
- |
|
| Herman James L |
VP and Chief Compliance Office |
• – – |
2023-03-18 |
4 |
D |
$1.92 |
$2,458 |
D/D |
(1,280) |
39,441 |
|
- |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2023-03-18 |
4 |
D |
$1.92 |
$71,434 |
D/D |
(37,205) |
5,716,153 |
|
- |
|
| Anthony Todd M. |
Vice Pres Organizational DevOf |
• – – |
2023-03-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,144 |
|
-32% |
|
| Bitterman Chris T. |
Vice Pres Sales & MarketingOff |
• – – |
2023-03-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,276 |
|
-32% |
|
| Jacobs Joey A |
Director |
– • – |
2023-01-14 |
4 |
D |
$2.75 |
$13,750 |
D/D |
(5,000) |
98,415 |
|
- |
|
| Galante Joseph C |
Director |
– • – |
2022-10-31 |
4 |
AB |
$2.54 |
$165 |
D/D |
65 |
54,441 |
|
-13% |
|
| Young Caroline |
Director |
– • – |
2022-10-31 |
4 |
AB |
$2.54 |
$51 |
D/D |
20 |
18,788 |
|
-13% |
|
| Krogulski Kenneth |
Director |
– • – |
2022-10-31 |
4 |
AB |
$2.54 |
$267 |
D/D |
105 |
199,700 |
|
-13% |
|
| Jones James |
Director |
– • – |
2022-10-31 |
4 |
AB |
$2.54 |
$79 |
D/D |
31 |
24,975 |
|
-13% |
|
2379 Records found
|
|
Page 12 of 96 |
|
|
0.04 (2.8%) 
